Maria Gabriella Camboni

EOS SpA engages in the manufacture of biopharmaceutical products. The company was founded by Silvano Spinelli, Gabriella Camboni, Ennio Cavalletti and Jacques Theurillat in June 2006 and is headquartered in Milan, Italy.

Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.

Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France.

Sandoz SpA manufactures pharmaceutical products. It develops and distributes medicines for cardiovascular systems, antibiotics, antidepressants, anti-asthmatics, calcium compounds, and laxatives. The company is headquartered in Origgio, Italy.

MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom.

Amypopharma Srl develops therapeutic solutions for protein disorders. It specializes in functionalized nanoliposomes to treat protein misfolding disorders. The company was founded by Massimo Ernesto Masserini and Francesca Re in 2015 and is headquartered in Milan, Italy.

PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy.